Pro Medicus Ltd locks in A$40 million U.S. renewals as MedStar adds heart-imaging tools

March 11, 2026
Pro Medicus Ltd locks in A$40 million U.S. renewals as MedStar adds heart-imaging tools

MELBOURNE, March 11, 2026, 10:38 AEDT

Pro Medicus announced Monday its U.S. arm locked in two renewed imaging software deals totaling at least A$40 million. The bigger slice, an A$31 million extension with MedStar Health, will bring new heart-imaging capabilities. Another A$9 million contract covers a renewal with Zwanger-Pesiri, a radiology group on Long Island.

Both renewals locked in higher per-transaction fees, and there’s still upside if scan volumes climb. They also push Pro Medicus further into the U.S. market, while the MedStar deal now stretches into cardiology.

These deals land just weeks after the Melbourne-based firm reported first-half revenue of A$124.8 million and an underlying profit before tax of A$90.7 million. Net profit came in at A$171.2 million, thanks in large part to an unrealised A$149.1 million gain from its 4D Medical stake. As of end-December, Pro Medicus was sitting on A$221.8 million in cash and other financial assets, with no debt.

Chief Executive Sam Hupert pointed out that the MedStar contract was notable as Pro Medicus’ inaugural full cloud deployment—the software operated from remote data centers instead of on-premise hospital servers. Adding cardiology demonstrated the platform’s “fully cloud native” capabilities, he said. Zwanger-Pesiri, meanwhile, has signed on for a third term. ASX Announcements

Back in February, Hupert told reporters Pro Medicus had landed seven fresh contracts in the half, together topping A$280 million at a minimum. That pushed the company’s locked-in minimum revenue for the next five years past A$1 billion for the first time. Cardiology—heart imaging—was also beginning to pick up interest from hospitals, he noted, joining diagnostic imaging in the lineup.

The MedStar deal isn’t just a simple rollover. With the updated contract covering viewer, archive, worklist, and cardiology modules, Pro Medicus is reaching further outside its core radiology business and edging into related specialty areas.

The space keeps heating up. Back in November, GE HealthCare announced a $2.3 billion deal to acquire imaging software maker Intelerad, aiming to strengthen its position in outpatient enterprise imaging—the tech that lets hospitals and clinics manage scans and share them within their networks.

This was a renewal, not a fresh client signing. And since these contracts hinge on transaction volume, any uptick relies partly on the number of studies getting processed. AI is a wild card for software names, but Hupert maintained that today’s tools mostly help doctors handle bigger caseloads—”play catchup,” as he put it—instead of knocking radiologists out of their jobs.

Cloud delivery has sped up rollouts, Hupert noted, citing Trinity Health implementations wrapped up late last year and then again in January. After last year’s RSNA meeting in Chicago—the key radiology event—he described the pipeline as “continues to be strong.” Pro Medicus, founded in 1983, maintains offices in Melbourne, Berlin, and San Diego. Pro Medicus

Stock Market Today

  • Australia King's Size Pillow Market Report 2024: Prices, Growth, Brands
    May 13, 2026, 4:32 PM EDT. The Australian king-size pillow market, defined by pillows measuring 20 x 36 inches, shows nuanced growth influenced by shopper needs, brand dynamics, and retail channels. This sector extends beyond product specs, shaped by price strategies, promotions, and route-to-market controls. The report analyzes market size, category boundaries, consumer segments, and channel structures from 2012 to projections for 2035. It highlights key questions about growth areas, brand control, pricing effects, and distribution routes. Brands and private labels vary in scale and market share, impacting shelf power and revenue quality. Understanding shopper behavior-entry, loyalty, and switching-and identifying white-space opportunities are vital for stakeholders. The study guides brand owners, retailers, and investors on where to focus resources for margin and scale, assessing commercial segments and supply chain factors crucial for competitive positioning in Australia's bedding accessory market.